期刊文献+

免疫血栓形成机制及相关研究进展

The mechanism of immune thrombosis and related research progress
下载PDF
导出
摘要 免疫血栓形成是指由血管内(特别是微血管内)血栓形成引起的先天免疫反应.免疫血栓形成与免疫细胞和特定的血栓形成相关分子有关,产生血管内支架,促进病原体的识别、抑制和破坏,从而保护宿主的完整性.但免疫血栓形成的异常或不受控制的激活可能对宿主有害,是多种感染性和炎症相关血栓性疾病的基础.因此,了解免疫血栓形成的潜在机制对于开发更有效的方法来治疗和预防血栓形成具有决定性作用.本文概述了有关免疫血栓形成的机制,以便了解降低免疫血栓形成风险的新治疗策略. Immunothrombosis refers to the innate immune response caused by thrombosis in blood vessels(especially microvessels).Immunothrombosis is related to immune cells and specific thrombosis related molecules,producing intravascular scaffolds that promote pathogen recognition,inhibition,and destruction,thereby protecting the integrity of the host.However,abnormal or uncontrolled activation of immunothrombosis may be harmful to the host and serve as the foundation for various infectious and inflammatory related thrombotic diseases.Therefore,understanding the potential mechanisms of immunothrombosis plays a decisive role in developing more effective therapies for thrombosis treatment and prevention.This review provides an overview of the mechanisms of immunothrombosis in order to understand new treatment strategies for reducing the risk of immunothrombosis.
作者 蒋佳维 杨蕊 包佳婷 张会红 高红梅 Jiang Jiawei;Yang Rui;Bao Jiating;Zhang Huihong;Gao Hongmei(Department of Critical Care Medicine,Tianjin First Central Hospital,Tianjin 300192,China;Key Laboratory for Critical Care Medicine of the Ministry of Health,Tianjin 300192,China)
出处 《中国中西医结合急救杂志》 CAS CSCD 北大核心 2023年第6期749-754,共6页 Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care
基金 天津市医学重点学科(专科)建设项目资助(TJYXZDXK-013A) 天津市科技计划项目(21JCYBJC0090) 天津市卫生健康科技项目(ZC20012)。
关键词 免疫血栓形成 中性粒细胞胞外诱捕网 血小板 Immunothrombosis Neutrophil extracellulartrapping network Platelet
  • 相关文献

参考文献7

二级参考文献97

  • 1李志军.脓毒症的中西医结合治疗对策[J].中国中西医结合急救杂志,2008,15(6):323-325. 被引量:23
  • 2陈兆永,邰宁正,孙炳伟.一氧化碳干预——脓毒症治疗的新进展[J].江苏大学学报(医学版),2006,16(1):78-81. 被引量:1
  • 3Zillmann A,Luther T,Muller I,et al. Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation [J]. Biochem Biophys Res Commun, 2001, 281(2):603-609.
  • 4Siddiqui F A, Desai H, Amirkhosravi A, et al. The presence and release of tissue factor from human platelets[J].Platelets,2002,13(4) :247-253.
  • 5Perez-Pujol S, Aras O,Lozano M,et al. Stored platelets contain residual amounts of tissue factor:evidence from studies on platelet concentrates stored for prolonged periods[J]. Transfusion, 2005,45 (4) : 572-579.
  • 6Osterud B. Tissue factor: a complex biological role [J]. Thromb Haemost, 1997,78 (1) : 755-758.
  • 7Price G C,Thompson S A,Kam P C. Tissue factor and tissue factor pathway inhibitor [J]. Anaesthesia, 2004,59 (5) : 483-492.
  • 8Piro O, Broze G J Jr. Role for the Kunitz-3 domain of tissue factor pathway inhibitor-α in cell surface hinding[J]. Circulation, 2004, 110 (23) : 3567-3572.
  • 9Kato H. Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: basic and clinical aspects[J]. Arterioscler Thromb Vasc Biol, 2002,22 (4):539-548.
  • 10Crawley J,Lupu F,Westmuckett A D, et al. Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels[J]. Arteioscler Thromb Vasc Boil,2000,20(5):1362-1373.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部